STOCK TITAN

Shareholder plans Rule 144 sale in SOPH (NASDAQ: SOPH)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder filed a Rule 144 notice to sell 760 shares of common stock with an aggregate market value of $4,142.00 through Morgan Stanley Smith Barney LLC on NASDAQ.

The shares to be sold were acquired as restricted stock units from the issuer on 01/18/2026, with 760 securities recorded as acquired. The filing notes total common shares outstanding of 67,847,058, providing context for the planned sale.

Over the prior three months, 10b5-1 sales for Ross J. Muken included multiple common stock transactions, such as 4,200 shares sold on 01/06/2026 for gross proceeds of $20,013.84, along with several smaller sales in late 2025.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many SOPH common shares are planned to be sold under this Rule 144 notice?

The notice covers the proposed sale of 760 shares of common stock, with an aggregate market value listed as $4,142.00, to be executed through Morgan Stanley Smith Barney LLC on NASDAQ.

What is the context of the 760 SOPH shares being sold?

The 760 shares planned for sale were acquired as restricted stock units from the issuer on 01/18/2026, with the same date shown for payment and the nature of payment described as N/A.

How many SOPH shares are reported as outstanding in this filing?

The Rule 144 notice lists a number of shares or other units outstanding of 67,847,058 common shares, providing a baseline figure relative to the 760 shares planned for sale.

Which broker and exchange are involved in this SOPH Rule 144 sale?

The filing identifies Morgan Stanley Smith Barney LLC Executive Financial Services as the broker for the transaction, with the common stock to be sold on the NASDAQ exchange.

What recent 10b5-1 sales by Ross J. Muken are disclosed for SOPH?

The document lists several 10b5-1 sales of common stock for Ross J. Muken, including 4,200 shares sold on 01/06/2026 for $20,013.84, 2,021 shares on 01/05/2026 for $9,319.64, and additional sales on 12/26/2025, 12/19/2025, and 11/19/2025.

What representation does the selling person make in this SOPH Rule 144 notice?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Sophia Genetics Sa

NASDAQ:SOPH

SOPH Rankings

SOPH Latest News

SOPH Latest SEC Filings

SOPH Stock Data

354.16M
63.48M
6.46%
48.2%
0.06%
Health Information Services
Healthcare
Link
Switzerland
Rolle